Pfizer (PFE) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Over ...

Pfizer Inc. (PFE), founded in 1849 and headquartered in New York City, is one of the world's largest pharmaceutical companies ...

Pfizer (NYSE:PFE – Get Free Report) had its price objective decreased by equities research analysts at Citigroup from $30.00 ...

Pfizer Inc. (NYSE:PFE – Get Free Report)’s share price traded down 0.6% during trading on Tuesday after Citigroup lowered their price target on the stock from $30.00 to $29.00. Citigroup currently has ...

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

On Friday, Pfizer Inc (PFE) stock saw a decline, ending the day at $26.09 which represents a decrease of $-0.35 or -1.32% from the prior close of $26.44. The stock opened at $26.02 and touched a low ...

If an investor was to purchase shares of PFE stock at the current price level of $26.07/share, and then sell-to-open that call contract as a "covered call," they are committing to sell the stock ...

Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Pfizer (PFE) closed the latest trading day at $26. ... these adjustments in estimates directly associate with imminent stock price performance. We developed the Zacks Rank to capitalize on this ...